The prevention of diabetes-associated birth defects

Area of Science:

• Obstetrics and Gynecology
• Developmental Biology
• Endocrinology

Background:

• Infants born to diabetic mothers have a high rate of birth defects, posing significant financial and psychosocial burdens.
• These malformations originate in early pregnancy and are linked to the maternal metabolic environment.
• Multiple factors likely contribute to the development of these defects.

Purpose of the Study:

• To investigate strategies for reducing birth defects in infants of diabetic mothers.
• To evaluate the impact of maternal metabolic control on embryogenesis.
• To explore the potential of arachidonic acid in preventing diabetes-related embryopathy.

Main Methods:

• Review of epidemiologic, clinical, and experimental studies.
• Analysis of the effects of periconceptual and first-trimester metabolic control in diabetic pregnancies.
• Examination of experimental data on arachidonic acid's role in preventing embryopathy.

Main Results:

• Optimal maternal metabolic control during the periconceptual period and first trimester significantly reduces malformation rates.
• Delaying conception until metabolic control is achieved is recommended for diabetic women.
• Arachidonic acid has emerged as a potential agent for pharmacologic prophylaxis against diabetes-related embryopathy.

Conclusions:

• Achieving optimal metabolic control before and during early pregnancy is crucial for preventing birth defects in infants of diabetic mothers.
• Diabetic women should consider delaying pregnancy until satisfactory metabolic status is attained.
• Arachidonic acid warrants further investigation as a preventive measure for diabetes-related embryopathy.